Systematic review, meta-analysis and economic modelling of ...

More documents

Recommendations

Info

References51. Potsch AA, Siqueira Filho AG, Tura BR, Gamarski R, Bassan R, Nogueira MV, et al. C-reactive proteindiagnostic and prognostic value in patients presenting at the emergency room with chest pain.Arq Bras Cardiol 2006;87:275–80.52. Amodio G, Antonelli G, Varraso L, Ruggieri V, Di SF, Amodio G, et al. Clinical impact of the troponin99th percentile cut-off and clinical utility of myoglobin measurement in the early managementof chest pain patients admitted to the Emergency Cardiology Department. Coron Artery Dis2007;18:181–6.53. Apple FS, Smith SW, Pearce LA, Ler R, Murakami MM, Benoit MO, et al. Use of the bioMerieuxVIDAS troponin I ultra assay for the diagnosis of myocardial infarction and detection of adverseevents in patients presenting with symptoms suggestive of acute coronary syndrome. Clin ChimActa 2008;390:72–5.54. Apple FS, Smith SW, Pearce LA, Ler R, Murakami MM. Use of the centaur TnI-Ultra assay fordetection of myocardial infarction and adverse events in patients presenting with symptomssuggestive of acute coronary syndrome. Clin Chem 2008;54:723–8.55. Apple FS, Smith SW, Pearce LA, Murakami MM, Apple FS, Smith SW, et al. Assessment of themultiple-biomarker approach for diagnosis of myocardial infarction in patients presenting withsymptoms suggestive of acute coronary syndrome. Clin Chem 2009;55:93–100.56. Bassan R, Potsch A, Maisel A, Tura B, Villacorta H, Nogueira MV, et al. B-type natriuretic peptide:a novel early blood marker of acute myocardial infarction in patients with chest pain and noST-segment elevation. Eur Heart J 2005;26:234–40.57. Body R, McDowell H, Carley S, Wibberley C, Ferguson J, Mackway-Jones K. A FABP-ulous ‘rule out’strategy? Heart fatty acid binding protein and troponin for rapid exclusion of acute myocardialinfarction. Resuscitation 2011;82:1041–6.58. Cete YE. The value of point-of-care fatty acid binding protein in patients with chest painin determining myocardial infarction in the emergency setting. Hong Kong J Emerg Med2010;17:224–9.59. Charpentier S, Ducasse JL, Cournot M, Maupas-Schwalm F, Elbaz M, Baixas C, et al. Clinicalassessment of ischemia-modified albumin and heart fatty acid-binding protein in the early diagnosisof non-ST-elevation acute coronary syndrome in the emergency department. Acad Emerg Med2010;17:27–35.60. Christ M, Popp S, Pohlmann H, Poravas M, Umarov D, Bach R, et al. Implementation ofHigh Sensitivity Cardiac Troponin T Measurement in the Emergency Department. Am J Med2010;123:1134–42.61. Christenson RH, Duh SH, Sanhai WR, Wu AHB, Holtman V, Painter P, et al. Characteristics of analbumin cobalt binding test for assessment of acute coronary syndrome patients: a multicenterstudy. Clin Chem 2001;47:464–70.62. Collinson PO, Gaze DC, Stubbs PJ, Swinburn J, Khan M, Senior R, et al. Diagnostic and prognosticrole of cardiac troponin I (cTnI) measured on the DPC Immulite. Clin Biochem 2006;39:692–6.63. Di Serio F, Amodio G, Ruggieri E, De Sario R, Varraso L, Antonelli G, et al. Proteomic approach tothe diagnosis of acute coronary syndrome: preliminary results. Clin Chim Acta 2005;357:226–35.64. Ecollan P, Collet JP, Boon G, Tanguy ML, Fievet ML, Haas R, et al. Pre-hospital detection of acutemyocardial infarction with ultra-rapid human fatty acid-binding protein (H-FABP) immunoassay.Int J Cardiol 2007;119:349–54.65. Esporcatte R, Rey HC, Rangel FO, Rocha RM, Filho HT, Dohmann HF, et al. Predictive value ofmyeloperoxidase to identify high risk patients admitted to the hospital with acute chest pain.Arq Bras Cardiol 2007;89:377–84.124NIHR Journals Library
DOI: 10.3310/hta17010 Health Technology Assessment 2013 Vol. 17 No. 166. Guo XF. The predictive value of the bedside troponin T test for patients with acute chest pain. ExpClin Cardiol 2006;11:298–301.67. Haltern G, Peiniger S, Bufe A, Reiss G, lker H, Scheffold T. Comparison of usefulness of heart-typefatty acid binding protein versus cardiac troponin T for diagnosis of acute myocardial infarction. AmJ Cardiol 2010;105:1–9.68. Hjortshoj S, Kristensen SR, Ravkilde J. Diagnostic value of ischemia-modified albumin in patientswith suspected acute coronary syndrome. Am J Emerg Med 2010;28:170–6.69. Ilva T, Eriksson S, Lund J, Porela P, Mustonen H, Pettersson K, et al. Improved early risk stratificationand diagnosis of myocardial infarction, using a novel troponin I assay concept. Eur J Clin Invest2005;35:112–16.70. Keating L, Benger JR, Beetham R, Bateman S, Veysey S, Kendall J, et al. The PRIMA study:presentation ischaemia-modified albumin in the emergency department. Emerg Med J2006;23:764–8.71. Keller T, Tzikas S, Zeller T, Czyz E, Lillpopp L, Ojeda FM, et al. Copeptin improves early diagnosis ofacute myocardial infarction. J Am Coll Cardiol 2010;55:2096–106.72. Lefevre GF. Multicenter evaluation of h-FABP semi-quantitative assay (Cardio Detect in centrallaboratory: the point in acute myocardial infarction diagnosis. Ann Biol Clin 2007;65:377–84.73. Li C, Li J, Liang X, Li X, Cui J, Yang Z, et al. Point-of-care test of heart-type fatty acid-binding proteinfor the diagnosis of early acute myocardial infarction. Acta Pharmacol Sin 2010;31:307–12.74. Liao J, Chan CP, Cheung YC, Lu JH, Luo Y, Cautherley GW, et al. Human heart-type fatty acid-bindingprotein for on-site diagnosis of early acute myocardial infarction. Int J Cardiol 2009;133:420–3.75. Mad P, Domanovits H, Fazelnia C, Stiassny K, ller G, Cseh A, et al. Human heart-type fatty-acidbindingprotein as a point-of-care test in the early diagnosis of acute myocardial infarction. QJM2007;100:203–10.76. McCann CJ, Glover BM, Menown IB, Moore MJ, McEneny J, Owens CG, et al. Novel biomarkersin early diagnosis of acute myocardial infarction compared with cardiac troponin T. Eur Heart J2008;29:2843–50.77. Mion MM, Novello E, Altinier S, Rocco S, Zaninotto M, Plebani M, et al. Analytical and clinicalperformance of a fully automated cardiac multi-markers strategy based on protein biochipmicroarray technology. Clin Biochem 2007;40:1245–51.78. Naroo GYM. Elevated heart-type fatty acid-binding protein predicts early myocardial injuryand aids in the diagnosis of non-ST elevation myocardial infarction. Hong Kong J Emerg Med2009;16:141–7.79. Penttilä K, Koukkunen H, Halinen M, Rantanen T, Pyörälä K, et al. Myoglobin, creatine kinase MBisoforms and creatine kinase MB mass in early diagnosis of myocardial infarction in patients withacute chest pain. Clin Biochem 2002;35:647–53.80. Reichlin T, Hochholzer W, Stelzig C, Laule K, Freidank H, Morgenthaler NG, et al. Incremental valueof copeptin for rapid rule out of acute myocardial infarction. J Am Coll Cardiol 2009;54:60–8.81. Rudolf V, Goldmann BU, Bös C, Rudolph TK, Klinke A, Friedrichs K, et al. Diagnostic valueof MPO plasma levels in patients admitted for suspected myocardial infarction. Int J Cardiol2011;153:267–71.82. Valle HA, Riesgo LG, Bel MS, Gonzalo FE, Sanchez MS, Oliva LI, et al. Clinical assessment of hearttypefatty acid binding protein in early diagnosis of acute coronary syndrome. Eur J Emerg Med2008;15:140–4.© Queen’s Printer and Controller of HMSO 2013. This work was produced by Goodacre et al. under the terms of a commissioning contract issued by the Secretary of Statefor Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journalsprovided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should beaddressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton SciencePark, Southampton SO16 7NS, UK.125
Page 1:
Health Technology AssessmentVOLUME
Page 7:
DOI: 10.3310/hta17010 Health Techno
Page 10 and 11:
ContentsAppendix 5 Expected discoun
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19:
Page 22 and 23:
BackgroundTABLE 1 Hospital admissio
Page 24 and 25:
Background2. investigation of the c
Page 26 and 27:
BackgroundComputed tomographic coro
Page 28 and 29:
Research questionsiii. the diagnost
Page 30 and 31:
Assessment of diagnostic and progno
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
Page 38 and 39:
Page 40 and 41:
Page 42 and 43:
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 54 and 55:
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 91 and 92:
Page 93 and 94: DOI: 10.3310/hta17010 Health Techno
Page 125: DOI: 10.3310/hta17010 Health Techno
Page 128 and 129: Discussionspecificity were 62% (95%
Page 130 and 131: Discussionneed for revascularisatio
Page 132 and 133: Discussionchanges in sensitivity an
Page 134 and 135: Discussionuncertainty about these p
Page 136 and 137: Discussiontroponin assays have bett
Page 138 and 139: ConclusionsSuggested research prior
Page 154 and 155: Appendix 144. heart-type fatty acid
Page 156 and 157: Appendix 1135. interleukin 33.mp. (
Page 158 and 159: Appendix 147. 37 and 45 (529)48. li
Page 164 and 165: Appendix 313. Fernandez Portales JG
Page 166 and 167: Appendix 346. Luscher MS, Ravkilde
Page 168 and 169: Appendix 316. Rao SV, Ohman EM, Gra
Page 195:
Page 198 and 199:
Appendix 9Clinical diagnosis of NST
Page 200 and 201:
Appendix 9respectively. Exercise EC
Page 202 and 203:
Appendix 93. Two reviewers will mak
Page 204 and 205:
Appendix 9The methodology used in t
Page 206 and 207:
Appendix 9ES (Information Resources
Page 208:
Appendix 923. Westwood ME, Whiting
show all

Systematic review, meta-analysis and economic modelling of ...

Create successful ePaper yourself

Delete template?

Save as template?